KIF1B Gene CMT2A1 NGS Genetic DNA Test
Introduction
The KIF1B Gene CMT2A1 NGS Genetic DNA Test is a significant diagnostic tool designed to identify genetic mutations associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1). This condition is a hereditary neurological disorder that affects the peripheral nerves, leading to muscle weakness and atrophy. Understanding your genetic predisposition can aid in early diagnosis and management of this condition.
What the Test Measures
This test utilizes Next-Generation Sequencing (NGS) technology to analyze the KIF1B gene for mutations that are known to cause CMT2A1. By detecting these mutations, the test provides insights into the likelihood of developing this neurological disorder.
Who Should Consider This Test?
Individuals with a family history of Charcot-Marie-Tooth disease or symptoms such as muscle weakness, sensory loss, or difficulty walking should consider this test. Risk factors include:
- Family history of neurological disorders
- Presence of symptoms associated with CMT2A1
- Individuals seeking clarity on unexplained neurological symptoms
Benefits of Taking the Test
- Early diagnosis and intervention strategies
- Informed family planning and genetic counseling options
- Access to targeted therapies and management plans
- Peace of mind through understanding genetic risks
Understanding Your Results
Results from the KIF1B Gene CMT2A1 NGS Genetic DNA Test will indicate whether any mutations are present in the KIF1B gene. A positive result may suggest a higher risk of developing CMT2A1, while a negative result can provide reassurance. It is important to discuss your results with a healthcare provider for comprehensive understanding and guidance.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KIF1B Gene CMT2A1 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test
To schedule the KIF1B Gene CMT2A1 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and any inquiries you may have.
Pre-Test Instructions
Patients are advised to undergo a genetic counseling session to draw a pedigree chart of family members affected with KIF1B Gene CMT2A1 prior to the test. This will provide essential context for your results.
Turnaround time for results is approximately 3 to 4 weeks, and the sample type required can be blood, extracted DNA, or one drop of blood on an FTA card.
